NO970892L - Isoksazolderivater - Google Patents

Isoksazolderivater

Info

Publication number: NO970892L
Authority: NO; Norway
Prior art keywords: group; ring; integer; alkylthio; amino
Prior art date: 1994-08-30

Application number

NO970892A

Other languages

English (en)

Other versions

NO308741B1 (no

NO970892D0 (no

Inventor

Koichi Kojima

Junichi Sakai

Yuichi Aizawa

Naozumi Samata

Masao Kozuka

Kenji Yoshimi

Isao Kaneko

Kazuro Koyama

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-30

Filing date

1997-02-27

Publication date

1997-04-29

1997-02-27 Application filed by Sankyo Co filed Critical Sankyo Co

1997-02-27 Publication of NO970892D0 publication Critical patent/NO970892D0/no

1997-04-29 Publication of NO970892L publication Critical patent/NO970892L/no

2000-10-23 Publication of NO308741B1 publication Critical patent/NO308741B1/no

Links

150000002545 isoxazoles Chemical class 0.000 title abstract 2
125000004414 alkyl thio group Chemical group 0.000 abstract 2
125000003277 amino group Chemical group 0.000 abstract 2
102000010909 Monoamine Oxidase Human genes 0.000 abstract 1
108010062431 Monoamine oxidase Proteins 0.000 abstract 1
208000018737 Parkinson disease Diseases 0.000 abstract 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000004423 acyloxy group Chemical group 0.000 abstract 1
125000005236 alkanoylamino group Chemical group 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
230000007823 neuropathy Effects 0.000 abstract 1
201000001119 neuropathy Diseases 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
230000003449 preventive effect Effects 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
239000011593 sulfur Substances 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO970892A 1994-08-30 1997-02-27 Isoksazolderivater, mellomprodukter, farmasøytiske preparater og anvendelse av derivatene NO308741B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP20536394		1994-08-30
JP15057195		1995-06-16
PCT/JP1995/001714 WO1996006837A1 (en)	1994-08-30	1995-08-29	Isoxazoles

Publications (3)

Publication Number	Publication Date
NO970892D0 NO970892D0 (no)	1997-02-27
NO970892L true NO970892L (no)	1997-04-29
NO308741B1 NO308741B1 (no)	2000-10-23

Family

ID=26480122

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO970892A NO308741B1 (no)	1994-08-30	1997-02-27	Isoksazolderivater, mellomprodukter, farmasøytiske preparater og anvendelse av derivatene

Country Status (19)

Country	Link
US (2)	US5965591A (no)
EP (1)	EP0779281B1 (no)
KR (1)	KR970705549A (no)
CN (1)	CN1098843C (no)
AT (1)	ATE253057T1 (no)
AU (1)	AU688102B2 (no)
CA (1)	CA2198457A1 (no)
CZ (1)	CZ290961B6 (no)
DE (1)	DE69532039T2 (no)
DK (1)	DK0779281T3 (no)
ES (1)	ES2208690T3 (no)
FI (1)	FI970864A7 (no)
HU (1)	HU221138B1 (no)
MX (1)	MX9701630A (no)
NO (1)	NO308741B1 (no)
NZ (1)	NZ291508A (no)
PT (1)	PT779281E (no)
RU (1)	RU2140414C1 (no)
WO (1)	WO1996006837A1 (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE253057T1 (de) *	1994-08-30	2003-11-15	Sankyo Co	Isoxazole
EP0885891A4 (en) *	1996-02-27	2001-02-21	Sankyo Co	ISOXAZOLE DERIVATIVES
US6339099B1 (en) *	1997-06-20	2002-01-15	Dupont Pharmaceuticals Company	Guanidine mimics as factor Xa inhibitors
AU1616600A (en) *	1998-11-12	2000-05-29	Eli Lilly And Company	Aminobenzisoxazole compounds and libraries thereof
US6497928B1 (en)	1999-05-14	2002-12-24	Canon Kabushiki Kaisha	Liquid crystal device, mesomorphic functional material and liquid crystal apparatus
DE10000577A1 (de)	2000-01-10	2001-07-26	Fumapharm Ag Muri	Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
US6638981B2 (en) *	2001-08-17	2003-10-28	Epicept Corporation	Topical compositions and methods for treating pain
US6660736B2 (en) *	2002-03-27	2003-12-09	Hoffmann-La Roche Inc.	Phthalimido derivatives and a process for their preparation
MY134480A (en) *	2002-09-20	2007-12-31	Hoffmann La Roche	4-pyrrolidino-phenyl-benzyl ether derivatives
RU2361862C2 (ru) *	2003-12-29	2009-07-20	Сепракор Инк.	Пиррольные и пиразольные ингибиторы daao
CN101798291A (zh) *	2003-12-29	2010-08-11	塞普拉科公司	苯并[d]异噁唑-3-醇DAAO抑制剂
US20070197610A1 (en) *	2004-03-16	2007-08-23	Janssen Pharmaceutica N.V.	Benzisoxazoles
RU2378270C2 (ru) *	2004-08-02	2010-01-10	Ф. Хоффманн-Ля Рош Аг	Бензилокси-производные в качестве ингибиторов моноаминоксидазы b
DE102005018389A1 (de) *	2005-04-20	2006-10-26	Sanofi-Aventis Deutschland Gmbh	Azolderivate als Inhibitoren von Lipasen und Phospholipasen
WO2007006003A2 (en)	2005-07-06	2007-01-11	Sepracor Inc.	Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
JP2009502922A (ja) *	2005-07-28	2009-01-29	バーテックスファーマシューティカルズインコーポレイテッド	カスパーゼ阻害剤プロドラッグ
BRPI0706365A2 (pt)	2006-01-06	2011-03-22	Sepracor Inc	Cicloalquilaminas como inibidores da recaptação de monoamina
US8053603B2 (en) *	2006-01-06	2011-11-08	Sunovion Pharmaceuticals Inc.	Tetralone-based monoamine reuptake inhibitors
RU2434002C2 (ru) *	2006-02-21	2011-11-20	Тояма Кемикал Ко., Лтд.	Способ получения сложного эфира 3-[5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-оксо-2-замещенный-2, 3-дигидро-1, 2-бензизоксазол-6-ил)метокси]фенил]пропионовой кислоты и промежуточного продукта для данного способа
EP2816024B8 (en)	2006-03-31	2018-04-04	Sunovion Pharmaceuticals Inc.	Chiral amines
US7579370B2 (en) *	2006-06-30	2009-08-25	Sepracor Inc.	Fused heterocycles
US7884124B2 (en) *	2006-06-30	2011-02-08	Sepracor Inc.	Fluoro-substituted inhibitors of D-amino acid oxidase
US20080082066A1 (en) *	2006-10-02	2008-04-03	Weyerhaeuser Co.	Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
US8012955B2 (en)	2006-12-28	2011-09-06	Rigel Pharmaceuticals, Inc.	N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
US7902252B2 (en) *	2007-01-18	2011-03-08	Sepracor, Inc.	Inhibitors of D-amino acid oxidase
EP2074092A2 (en) *	2007-01-18	2009-07-01	Sepracor Inc.	Inhibitors of d-amino acid oxidase
CA2688493C (en)	2007-05-31	2016-04-19	Sepracor Inc.	Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
CA2716080C (en)	2008-02-20	2016-12-13	Targia Pharmaceuticals	Cns pharmaceutical compositions and methods of use
WO2010017418A1 (en) *	2008-08-07	2010-02-11	Sepracor Inc.	Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US20110034434A1 (en) *	2009-08-07	2011-02-10	Sepracor Inc.	Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
JP2013519685A (ja)	2010-02-11	2013-05-30	ヴァンダービルトユニバーシティー	ｍＧｌｕＲ４アロステリック増強剤としてのベンズイソオキサゾール類およびアザベンズイソオキサゾール類、組成物、および神経機能不全を治療する方法
WO2013064983A1 (en)	2011-10-31	2013-05-10	Xenon Pharmaceuticals Inc.	Benzenesulfonamide compounds and their use as therapeutic agents
EP2773641B1 (en)	2011-10-31	2017-09-27	Xenon Pharmaceuticals Inc.	Biaryl ether sulfonamides and their use as therapeutic agents
SG11201408284VA (en)	2012-05-22	2015-02-27	Xenon Pharmaceuticals Inc	N-substituted benzamides and their use in the treatment of pain
US10071957B2 (en)	2012-07-06	2018-09-11	Genentech, Inc.	N-substituted benzamides and methods of use thereof
RU2015143906A (ru)	2013-03-14	2017-04-18	Дженентек, Инк.	Замещенные триазолопиридины и способы их применения
CN105492430B (zh) *	2013-03-15	2017-10-10	基因泰克公司	取代的苯并噁唑及其使用方法
US9493429B2 (en)	2013-03-15	2016-11-15	Genentech, Inc.	Substituted benzoxazoles and methods of use thereof
AU2014356967A1 (en)	2013-11-27	2016-07-07	Genentech, Inc.	Substituted benzamides and methods of use thereof
JP2017525677A (ja)	2014-07-07	2017-09-07	ジェネンテック，インコーポレイテッド	治療用化合物及びその使用方法
BR112017024853A2 (pt)	2015-05-22	2018-08-07	Genentech Inc	composto, composição farmacêutica, método para tratar uma doença ou condição em um mamífero, para tratamento de prurido em um mamífero, para tratamento ou profilaxia e uso de um composto
MA42683A (fr)	2015-08-27	2018-07-04	Genentech Inc	Composés thérapeutiques et leurs méthodes utilisation
JP2018535234A (ja)	2015-11-25	2018-11-29	ジェネンテック，インコーポレイテッド	ナトリウムチャネル遮断薬として有用な置換ベンズアミド
WO2017172802A1 (en)	2016-03-30	2017-10-05	Genentech, Inc.	Substituted benzamides and methods of use thereof
CN105801510A (zh) *	2016-04-08	2016-07-27	李勇	一种治疗抑郁症的药物组合物
SG11201903348UA (en)	2016-10-17	2019-05-30	Genentech Inc	Therapeutic compounds and methods of use thereof
CN110546148A (zh)	2017-03-24	2019-12-06	基因泰克公司	作为钠通道抑制剂的4-哌啶-n-(嘧啶-4-基)色满-7-磺酰胺衍生物
EP3759098A1 (en)	2018-02-26	2021-01-06	Genentech, Inc.	Pyridine-sulfonamide compounds and their use against pain and related conditions
CN111936494A (zh)	2018-03-30	2020-11-13	豪夫迈·罗氏有限公司	作为钠通道抑制剂的取代的氢-吡啶并-吖嗪
TW202003490A (zh)	2018-05-22	2020-01-16	瑞士商赫孚孟拉羅股份公司	治療性化合物及其使用方法
CN114349690B (zh) *	2022-02-15	2023-04-25	甘肃皓天医药科技有限责任公司	一种多拉韦林中间体合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1265824A (no) *	1968-03-28	1972-03-08
US3812187A (en) *	1970-02-05	1974-05-21	Merck & Co Inc	Hydrazides
SU539522A3 (ru) *	1970-02-05	1976-12-15	Мерк Энд Ко. Инк. (Фирма)	Способ получени гидразин- -фенилпропионовой кислоты
JPS476302Y1 (no) *	1970-06-08	1972-03-04
US5321037A (en) *	1986-12-26	1994-06-14	Sankyo Company, Limited	Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
IE62276B1 (en) *	1988-03-30	1995-01-25	Sankyo Co	"New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants"
US5116839A (en) *	1989-06-26	1992-05-26	Sankyo Company, Limited	Use of isoxazolin-3-one derivatives as antidepressants
US5352688A (en) *	1991-02-14	1994-10-04	The Mount Sinai School Of Medicine Of The City University Of New York	Methods for the treatment of bradyphrenia in parkinson's disease
US5750542A (en) *	1993-09-28	1998-05-12	Pfizer	Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
JPH0588630A (ja) *	1991-09-30	1993-04-09	Toshiba Lighting & Technol Corp	表示装置
KR100263428B1 (ko) *	1992-10-28	2000-11-01	나카노 가쓰히코	신규한1,2-벤조이속사졸유도체또는그의염,및이를포함하는뇌보호제
US5494908A (en) *	1992-11-23	1996-02-27	Hoechst-Roussel Pharmaceutical Incorporated	Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
ATE253057T1 (de) *	1994-08-30	2003-11-15	Sankyo Co	Isoxazole
CA2190708A1 (en) *	1995-12-08	1997-06-09	Johannes Aebi	Aminoalkyl substituted benzo-heterocyclic compounds
JP5229734B2 (ja) *	2008-11-26	2013-07-03	住化エンビロサイエンス株式会社	木材保存組成物

1995
- 1995-08-29 AT AT95929249T patent/ATE253057T1/de not_active IP Right Cessation
- 1995-08-29 DK DK95929249T patent/DK0779281T3/da active
- 1995-08-29 ES ES95929249T patent/ES2208690T3/es not_active Expired - Lifetime
- 1995-08-29 HU HU9701740A patent/HU221138B1/hu not_active IP Right Cessation
- 1995-08-29 CN CN95195758A patent/CN1098843C/zh not_active Expired - Fee Related
- 1995-08-29 CZ CZ1997598A patent/CZ290961B6/cs not_active IP Right Cessation
- 1995-08-29 AU AU32660/95A patent/AU688102B2/en not_active Ceased
- 1995-08-29 RU RU97103132/04A patent/RU2140414C1/ru not_active IP Right Cessation
- 1995-08-29 NZ NZ291508A patent/NZ291508A/xx unknown
- 1995-08-29 WO PCT/JP1995/001714 patent/WO1996006837A1/ja not_active Ceased
- 1995-08-29 MX MX9701630A patent/MX9701630A/es unknown
- 1995-08-29 PT PT95929249T patent/PT779281E/pt unknown
- 1995-08-29 CA CA002198457A patent/CA2198457A1/en not_active Abandoned
- 1995-08-29 DE DE69532039T patent/DE69532039T2/de not_active Expired - Fee Related
- 1995-08-29 KR KR1019970701279A patent/KR970705549A/ko not_active Abandoned
- 1995-08-29 EP EP95929249A patent/EP0779281B1/en not_active Expired - Lifetime
1997
- 1997-02-26 US US08/806,854 patent/US5965591A/en not_active Expired - Fee Related
- 1997-02-27 NO NO970892A patent/NO308741B1/no unknown
- 1997-02-28 FI FI970864A patent/FI970864A7/fi not_active IP Right Cessation
1999
- 1999-02-03 US US09/243,885 patent/US6096771A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE253057T1 (de)	2003-11-15
HU221138B1 (en)	2002-08-28
EP0779281A1 (en)	1997-06-18
US6096771A (en)	2000-08-01
DE69532039D1 (de)	2003-12-04
KR970705549A (ko)	1997-10-09
FI970864A7 (fi)	1997-04-24
ES2208690T3 (es)	2004-06-16
NO308741B1 (no)	2000-10-23
WO1996006837A1 (en)	1996-03-07
DK0779281T3 (da)	2004-03-08
HK1018878A1 (en)	2000-01-07
AU3266095A (en)	1996-03-22
CN1162957A (zh)	1997-10-22
FI970864A0 (fi)	1997-02-28
RU2140414C1 (ru)	1999-10-27
CZ59897A3 (en)	1997-07-16
MX9701630A (es)	1997-06-28
CZ290961B6 (cs)	2002-11-13
AU688102B2 (en)	1998-03-05
NO970892D0 (no)	1997-02-27
DE69532039T2 (de)	2004-07-08
HUT77225A (hu)	1998-03-02
CA2198457A1 (en)	1996-03-07
US5965591A (en)	1999-10-12
NZ291508A (en)	1999-07-29
EP0779281A4 (en)	2000-07-26
EP0779281B1 (en)	2003-10-29
PT779281E (pt)	2004-02-27
CN1098843C (zh)	2003-01-15

Publication	Publication Date	Title
NO970892L (no)	1997-04-29	Isoksazolderivater
ATE180468T1 (de)	1999-06-15	Anthranilsäure derivate
ATE286026T1 (de)	2005-01-15	Amid-derivate und deren medizinische verwendung
NZ330973A (en)	2000-03-27	Azolobenzazepine derivatives as neurologically active agents
NO20020968L (no)	2002-04-26	Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
AU7517400A (en)	2001-04-24	N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
NZ286716A (en)	1997-08-22	Phenoxy- and phenylthio-alkyl benzimidazole derivatives and pharmaceutical compositions
AU5162396A (en)	1996-10-23	Protective agent for organ or tissue
NZ334701A (en)	2001-01-26	Dihydropyrones and use in treating retrovirus infections and diseases
EP0885891A4 (en)	2001-02-21	ISOXAZOLE DERIVATIVES
EP1034783A4 (en)	2001-03-28	AMIDE DERIVATIVES
EP0889033A4 (no)	1999-02-17
GR3036029T3 (en)	2001-09-28	Optically active thiazolidinone derivatives
NO20012443D0 (no)	2001-05-18	Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel
EP0784973A3 (en)	1999-12-15	Quinoxaline derivatives for treating tinnitus
AU6118798A (en)	1998-09-22	Remedies for peripheral circulation disturbances